Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

HIV infection and HERV expression: a review.

van der Kuyl AC.

Retrovirology. 2012 Jan 16;9:6. doi: 10.1186/1742-4690-9-6. Review.

2.

Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.

Subramanian RP, Wildschutte JH, Russo C, Coffin JM.

Retrovirology. 2011 Nov 8;8:90. doi: 10.1186/1742-4690-8-90.

3.

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, Emenyonu N, Kembabazi A, Neilands TB, Bangsberg DR, Deeks SG, Martin JN.

AIDS. 2011 Nov 13;25(17):2123-31. doi: 10.1097/QAD.0b013e32834c4ac1.

4.

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF.

PLoS One. 2011;6(7):e21135. doi: 10.1371/journal.pone.0021135. Epub 2011 Jul 19.

5.

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF.

J Virol. 2011 Jul;85(14):6977-85. doi: 10.1128/JVI.00179-11. Epub 2011 Apr 27.

6.

Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens.

Punkosdy GA, Blain M, Glass DD, Lozano MM, O'Mara L, Dudley JP, Ahmed R, Shevach EM.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3677-82. doi: 10.1073/pnas.1100213108. Epub 2011 Feb 14.

7.

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.

Nakanjako D, Ssewanyana I, Mayanja-Kizza H, Kiragga A, Colebunders R, Manabe YC, Nabatanzi R, Kamya MR, Cao H.

BMC Infect Dis. 2011 Feb 8;11:43. doi: 10.1186/1471-2334-11-43.

8.

Dynamic control of endogenous retroviruses during development.

Rowe HM, Trono D.

Virology. 2011 Mar 15;411(2):273-87. doi: 10.1016/j.virol.2010.12.007. Epub 2011 Jan 20. Review.

9.

A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation.

Li F, Nellåker C, Yolken RH, Karlsson H.

BMC Genomics. 2011 Jan 12;12:22. doi: 10.1186/1471-2164-12-22.

10.
11.

Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10.

Rodríguez-García M, Porichis F, de Jong OG, Levi K, Diefenbach TJ, Lifson JD, Freeman GJ, Walker BD, Kaufmann DE, Kavanagh DG.

J Leukoc Biol. 2011 Apr;89(4):507-15. doi: 10.1189/jlb.0610327. Epub 2010 Nov 19.

12.

Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Espinosa E, Ormsby CE, Reyes-Terán G, Asaad R, Sieg SF, Lederman MM.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):439-45. doi: 10.1097/QAI.0b013e3181ef991d.

13.

Reduction of immune activation with chloroquine therapy during chronic HIV infection.

Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, Schacker TW, Brenchley JM, Douek DC.

J Virol. 2010 Nov;84(22):12082-6. doi: 10.1128/JVI.01466-10. Epub 2010 Sep 15.

14.

Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer.

Romanish MT, Cohen CJ, Mager DL.

Semin Cancer Biol. 2010 Aug;20(4):246-53. doi: 10.1016/j.semcancer.2010.05.005. Epub 2010 May 26. Review.

PMID:
20685251
15.

HERVs in neuropathogenesis.

Christensen T.

J Neuroimmune Pharmacol. 2010 Sep;5(3):326-35. doi: 10.1007/s11481-010-9214-y. Epub 2010 Apr 27. Review.

PMID:
20422298
16.

A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.

Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG, Nelson PN.

Clin Exp Immunol. 2010 Jun;160(3):340-7. doi: 10.1111/j.1365-2249.2010.04110.x. Epub 2010 Mar 16.

17.

Antiretroviral therapy in the clinic.

Tsibris AM, Hirsch MS.

J Virol. 2010 Jun;84(11):5458-64. doi: 10.1128/JVI.02524-09. Epub 2010 Feb 24. Review.

18.

Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia.

Huang W, Li S, Hu Y, Yu H, Luo F, Zhang Q, Zhu F.

Schizophr Bull. 2011 Sep;37(5):988-1000. doi: 10.1093/schbul/sbp166. Epub 2010 Jan 25.

19.

Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa.

Compston LI, Li C, Sarkodie F, Owusu-Ofori S, Opare-Sem O, Allain JP.

J Med Virol. 2009 Nov;81(11):1860-8. doi: 10.1002/jmv.21614.

PMID:
19774687
20.

Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.

Gasser O, Bihl F, Sanghavi S, Rinaldo C, Rowe D, Hess C, Stablein D, Roland M, Stock P, Brander C.

Am J Transplant. 2009 Apr;9(4):794-803. doi: 10.1111/j.1600-6143.2008.02539.x.

Supplemental Content

Support Center